Northwest Bancshares(DE:NHS)
€13.50+0.10 (+0.75%)
DE:NHS
Northwest Bancshares financials statements
€13.50
At close:+0.10 (+0.75%)
Northwest Bancshares (NHS) Ratios
0 Followers
Northwest Bancshares Ratios
DE:NHS's free cash flow for Q3 2026 was $18.89M. For the 2026 fiscal year, DE:NHS's free cash flow was decreased by $-7.82M and operating cash flow was $26.71M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.13 | 0.12 | 0.10 | 0.11 | 0.23 |
| Quick Ratio | 0.13 | 0.12 | 0.10 | 0.11 | 0.23 |
| Cash Ratio | 0.02 | 0.02 | 0.01 | 0.01 | 0.10 |
| Solvency Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Operating Cash Flow Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.64 | 0.23 | 0.26 | 1.48 |
| Net Current Asset Value | $ -13.00B | $ -11.37B | $ -11.65B | $ -11.23B | $ -10.06B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.03 | 0.04 | 0.07 | 0.03 |
| Debt-to-Equity Ratio | 0.24 | 0.28 | 0.41 | 0.62 | 0.25 |
| Debt-to-Capital Ratio | 0.19 | 0.22 | 0.29 | 0.38 | 0.20 |
| Long-Term Debt-to-Capital Ratio | 0.19 | 0.13 | 0.14 | 0.14 | 0.14 |
| Financial Leverage Ratio | 8.87 | 9.02 | 9.29 | 9.46 | 9.16 |
| Debt Service Coverage Ratio | 0.56 | 0.28 | 0.29 | 0.20 | 0.97 |
| Interest Coverage Ratio | 0.73 | 0.55 | 1.15 | 6.18 | 7.38 |
| Debt to Market Cap | 0.25 | 0.27 | 0.40 | 0.52 | 0.22 |
| Interest Debt Per Share | 4.57 | 5.34 | 6.24 | 7.48 | 3.32 |
| Net Debt to EBITDA | 1.29 | 1.04 | 2.61 | 4.36 | -4.27 |
| Profitability Margins | |||||
| Gross Profit Margin | 68.32% | 65.77% | 74.99% | 89.88% | 97.85% |
| EBIT Margin | 18.79% | 17.18% | 25.01% | 31.14% | 37.65% |
| EBITDA Margin | 18.80% | 20.01% | 28.51% | 32.29% | 38.90% |
| Operating Profit Margin | 18.79% | 17.18% | 25.01% | 31.14% | 37.65% |
| Pretax Profit Margin | 18.79% | 17.18% | 25.01% | 31.14% | 37.65% |
| Net Profit Margin | 14.37% | 13.30% | 19.28% | 23.96% | 28.89% |
| Continuous Operations Profit Margin | 14.37% | 13.30% | 19.28% | 23.96% | 28.89% |
| Net Income Per EBT | 76.48% | 77.41% | 77.08% | 76.96% | 76.73% |
| EBT Per EBIT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Return on Assets (ROA) | 0.75% | 0.70% | 0.94% | 0.95% | 1.06% |
| Return on Equity (ROE) | 6.67% | 6.28% | 8.70% | 8.96% | 9.75% |
| Return on Capital Employed (ROCE) | 5.84% | 6.30% | 8.64% | 8.84% | 9.77% |
| Return on Invested Capital (ROIC) | 4.46% | 4.44% | 5.56% | 5.05% | 7.02% |
| Return on Tangible Assets | 0.77% | 0.72% | 0.96% | 0.97% | 1.09% |
| Earnings Yield | 7.16% | 5.99% | 8.49% | 7.51% | 8.64% |
| Efficiency Ratios | |||||
| Receivables Turnover | 15.58 | 16.27 | 14.78 | 15.70 | 20.87 |
| Payables Turnover | 40.59 | 37.22 | 12.81 | 17.47 | 6.35 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 6.25 | 6.07 | 5.04 | 3.82 | 3.41 |
| Asset Turnover | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 |
| Working Capital Turnover Ratio | -0.08 | -0.07 | -0.06 | -0.05 | -0.06 |
| Cash Conversion Cycle | 14.44 | 12.63 | -3.80 | 2.35 | -39.97 |
| Days of Sales Outstanding | 23.43 | 22.44 | 24.69 | 23.25 | 17.49 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 8.99 | 9.81 | 28.49 | 20.90 | 57.47 |
| Operating Cycle | 23.43 | 22.44 | 24.69 | 23.25 | 17.49 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.05 | 1.01 | 0.73 | 1.38 | 1.63 |
| Free Cash Flow Per Share | 0.97 | 0.99 | 0.66 | 1.34 | 1.49 |
| Dividend Paid and CapEx Coverage Ratio | 1.26 | 1.23 | 0.84 | 1.66 | 1.74 |
| Capital Expenditure Coverage Ratio | 13.19 | 55.31 | 10.85 | 40.61 | 11.73 |
| Operating Cash Flow Coverage Ratio | 0.34 | 0.29 | 0.14 | 0.19 | 0.52 |
| Operating Cash Flow to Sales Ratio | 0.17 | 0.17 | 0.13 | 0.31 | 0.38 |
| Free Cash Flow Yield | 8.05% | 7.49% | 5.31% | 9.61% | 10.52% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 12.90 | 16.70 | 11.77 | 13.31 | 11.58 |
| Price-to-Sales (P/S) Ratio | 2.01 | 2.22 | 2.27 | 3.19 | 3.35 |
| Price-to-Book (P/B) Ratio | 0.93 | 1.05 | 1.02 | 1.19 | 1.13 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 12.42 | 13.36 | 18.84 | 10.40 | 9.51 |
| Price-to-Operating Cash Flow Ratio | 11.48 | 13.11 | 17.11 | 10.14 | 8.70 |
| Price-to-Earnings Growth (PEG) Ratio | 0.73 | -0.66 | 12.36 | -0.96 | 0.12 |
| Enterprise Value Multiple | 11.96 | 12.13 | 10.57 | 14.24 | 4.33 |
| Enterprise Value | 1.97B | 1.83B | 2.11B | 2.56B | 899.20M |
| EV to EBITDA | 11.96 | 12.13 | 10.57 | 14.24 | 4.33 |
| EV to Sales | 2.25 | 2.43 | 3.01 | 4.60 | 1.68 |
| EV to Free Cash Flow | 13.92 | 14.60 | 25.01 | 14.99 | 4.78 |
| EV to Operating Cash Flow | 12.86 | 14.34 | 22.71 | 14.62 | 4.38 |
| Tangible Book Value Per Share | 9.59 | 9.56 | 9.15 | 8.66 | 9.43 |
| Shareholders’ Equity Per Share | 12.89 | 12.58 | 12.18 | 11.72 | 12.55 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.24 | 0.23 | 0.23 | 0.23 | 0.23 |
| Revenue Per Share | 5.98 | 5.94 | 5.50 | 4.38 | 4.23 |
| Net Income Per Share | 0.86 | 0.79 | 1.06 | 1.05 | 1.22 |
| Tax Burden | 0.76 | 0.77 | 0.77 | 0.77 | 0.77 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.30 | 0.31 | 0.29 | 0.35 | 0.37 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Income Quality | 1.22 | 1.27 | 0.69 | 1.31 | 1.33 |
Currency in USD
